Nano cap Moleculin Biotech (NASDAQ:MBRX) is up 8% premarket on increased volume in reaction to its announcement that it will host a conference call on Wednesday, April 24, at 4:30 pm ET to discuss its “significant discovery” for lung cancer, FDA Fast Track designation and recent corporate events.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.